Private Equity
IMM RoseGold IV is already about one-third deployed across four investments, including the $500m carve-out of Genuone Sciences.
2 min read · 17 December 2020
Fund IV is the largest fund in Gridiron's 15-year history, exceeding by 59 percent the $850 million collected four years ago by Fund III.
3 min read · 17 December 2020
Buyouts' annual study surveying 100 LPs revealed strong confidence in their private equity portfolios and an overwhelming majority planning to either maintain or increase their PE allocations.
3 min read · 16 December 2020
The firm is one of several high-profile GPs using the secondaries market to move assets out of older funds for more time to manage them.
2 min read · 16 December 2020
The US public pension has backed a North American secondaries vehicle.
1 min read · 16 December 2020
Four out of seven private equity transactions worth more than $1bn in enterprise value this year involved VC-backed companies, according to investment firm Atomico.
2 min read · 16 December 2020
What Blackstone’s $3.45 billion portfolio acquisition says about life science; how the firm formerly known as Meyer Bergman fared with its first fund; Prologis’s outlook on logistics demand; and more in today's briefing, exclusively for our valued subscribers.
4 min read · 16 December 2020
In June the US Department of Labor gave the green light for the incorporation of private equity into 401(k) plans. Don’t expect a rush of capital just yet.
2 min read · 16 December 2020
The onset of the coronavirus presented a vital question to private equity managers – should they accept state support or not?
2 min read · 16 December 2020
Sagard launched its credit strategy in 2017 under the leadership of managing partner and CIO Adam Vigna, ex-head of CPPIB’s global principal credit investments.
2 min read · 16 December 2020
